European medical technology business to  be discussed at IN3 Europe April 29-30, 2010

16 March 2010

Elsevier Business Intelligence will host 'IN3 Europe' on April 29-30, 2010, at The Marriott Rive Gauche, Paris. This annual conference follows 'Medical Device Investor Day,' also being held at The Marriott Rive Gauche, on April 28th, 2010.

IN3 Europe is one of the largest annual strategic partnership and investment meetings in Europe for senior-level medical technology executives. An audience of several hundred, including venture capital firms and other investors in the medtech sector, is expected to attend IN3 Europe to hear from more than 40 emerging medical technology companies seeking funding and/or strategic partnerships.

IN3 Europe will commence with a panel discussion: "Trends in European Dealmaking and Investing," which will be moderated by David Cassak, Managing Director, Elsevier Business Intelligence. Experts will include: Arthur Franken, Managing Partner, Gilde Healthcare Partners; Tim Haines, Partner, Abigworth; Olivier Litzka, Partner Life Sciences, Rothschilds; John Milad, Investment manager, NBGI; Antoine Papiernik, Managing Partner, Sofinnova Partners; Thom Rasche, Early Bird Ventures; and, Jay Watkins, Managing Director, De Novo Ventures.

Medical Device Investor Day will precede IN3 Europe and will appeal to medtech innovators interested in what medical technology investment leaders are thinking, doing, and planning.

Venture and corporate investment professionals will speak about what interests them most among medical device technologies: therapeutic areas, products, and geographic markets.

They will also discuss partnering opportunities, how to maximize visibility in front of large-company investors, and elaborate on their appetite for M&A activities in the near term.

Participants from the podium will include Abingworth LLP, Boston Scientific, Capricorn Venture Partners NW, Credit Agricole Private Equity, Delta Partners, De Novo Ventures, Earlybird Venture Capital, Edmond de Rothschild Investment Partners, Index Ventures, LSP, NBGI Ventures, Seventure Partners, Sofimac Partners SA, Sofinnova Partners, Wellington Partners, and Ysios Capital, among others.

Further information

For more information about IN3 Europe and Medical Device Investor Day, please contact: Kristy Grimes at 1-480-985-9512 or Kayleen Kell at 1-888-290-2225 (USA only), or email in3@elsevier.com

Additional IN3 events will be held in 2010-June 9-11, IN3 East, Boston (www.in3east.com), The Westin Copley Place; Oct. 27-29, IN3 Summit, San Francisco, Grand Hyatt.

For more information, please contact: Kristy Grimes at 1-480-985-9512 or Kayleen Kell at 1-888-290-2225 (USA only), or email: in3@elsevier.com